Levels Health Review: The CGM Protocol That Replaces Dietary Guesswork

In 2015, researchers at the Weizmann Institute published a study in Cell that quietly invalidated decades of nutritional consensus. Eran Segal, Eran Elinav, and their colleagues recruited 800 participants, fitted each with a continuous glucose monitor, and fed them precisely controlled meals. The finding was stark: identical foods produced wildly different postprandial glucose responses between individuals. One participant’s blood sugar barely moved after eating white rice. Another’s spiked to near-diabetic levels after the same portion. The difference was not marginal — responses frequently varied by a factor of five to ten between individuals eating identical meals.

This result has a uncomfortable implication that the nutrition industry has largely declined to confront. The Glycemic Index — the foundational tool used to rank foods by their blood sugar impact — is a population average. It was constructed by measuring glucose responses across groups of people and computing a mean. When you consult the GI of a food and use it to make a dietary decision, you are applying a population statistic to your individual biology. For some people, that average will be accurate. For many, it will be meaningfully wrong. There is no way to know which category you fall into without measuring.

Most dietary advice is built on the same structural problem. Low-carb works for some and produces no meaningful improvement in others. Mediterranean diets reduce cardiovascular markers in population studies but may not move the needle for a specific individual. Intermittent fasting produces metabolic improvements on average, but individual response varies significantly based on insulin sensitivity, cortisol patterns, and sleep quality. The problem is not that these approaches are wrong — it is that they are population-level interventions applied without individual-level feedback. Levels Health is a product built to solve exactly that problem.

The Problem: Dietary Optimization Without Data

Without real-time metabolic feedback, dietary optimization is reverse-engineering in the dark. You observe symptoms — energy crashes at 3pm, difficulty concentrating after lunch, unexplained weight changes, variable athletic performance — and then attempt to reason backward to dietary causes, often days or weeks after the fact. The signal is buried under noise. Correlation is impossible to establish when the cause and effect are separated by hours and mediated by dozens of confounding variables.

Continuous glucose monitoring addresses this by closing the feedback loop. A CGM is a small sensor, typically worn on the upper arm, that samples glucose in the interstitial fluid every one to five minutes and transmits readings wirelessly to a smartphone. The technology was originally developed for clinical management of Type 1 and Type 2 diabetes, where real-time glucose data is medically necessary. The sensors currently used in consumer metabolic programs — primarily the Abbott FreeStyle Libre 3 and the Dexcom G7 — are the same hardware used in clinical settings, simply accessed through a different software interface.

What CGMs provide for non-diabetic users is something that has never previously been available: a continuous, objective record of how your individual metabolism responds to food, exercise, sleep, and stress. You eat a meal and within fifteen to twenty minutes you can observe the glucose response on your phone. You sleep poorly and you can see the impact on fasting glucose the following morning. You take a ten-minute walk after lunch and you can watch the glucose curve flatten in real time. The feedback loop that previously operated on a timescale of weeks — eating a certain way, waiting for results, adjusting — compresses to hours.

Levels Health, founded in 2019 by Sam Corcos, was the first company to build a consumer-facing software layer that converts raw CGM data into structured metabolic insights for non-diabetic users. The core idea is straightforward: take clinical-grade glucose hardware, add an app that contextualizes the data with meal logging, activity tracking, and sleep overlays, and provide actionable guidance based on the patterns that emerge.

The Legitimate Objections

Before examining what Levels does well, the objections to the product deserve direct treatment. They are real, and for some potential users, they are decisive.

Price. The standard Levels subscription is $199 per month. This includes two Abbott FreeStyle Libre 3 sensors per month (each worn continuously for fourteen days), access to the app, and the underlying software platform. The Pro tier, at $249 per month, adds a monthly coaching call with a metabolic health coach. At $199/month, the annualized cost is $2,388. This is a significant sum. The case for value depends entirely on what you do with the information, and not every user extracts enough actionable insight to justify that cost on an ongoing basis.

Prescription requirements. CGM sensors are classified as medical devices. In the United States, they require a prescription. Levels routes this through a telehealth partner: new users complete a brief medical consultation (typically asynchronous, taking a few minutes) before sensors are approved. The process is straightforward and legal, but it adds friction and is an additional dependency on third-party medical infrastructure.

Glucose is one variable in a complex system. Some metabolic health researchers argue that the consumer CGM category has over-indexed on glucose stability as a proxy for metabolic health. Glucose does not capture insulin secretion volume (you can have a flat glucose curve while secreting very large amounts of insulin to achieve it). It does not capture cortisol, inflammation markers, lipid profiles, or HRV. A glucose-centric view of metabolism is more complete than no data, but it is still a partial picture.

Geographic limitations. Levels operates primarily in the US market. International users face a combination of regulatory complexity around CGM access, shipping constraints, and limited telehealth coverage. Users outside the US interested in CGM-based metabolic monitoring should investigate Supersapiens (EU-focused) or direct CGM purchase through local pharmacies where available.

What the Product Actually Delivers

The reframe that makes Levels coherent as a product: it is not a diet app. It is a closed-loop feedback system for metabolic experimentation. The value is not in the app’s recommendations — it is in the speed of the feedback loop it creates. Instead of experimenting with a dietary change and waiting weeks to observe results through body composition, energy levels, or blood work, you observe the metabolic response within twenty minutes of eating. The experimental cycle compresses from weeks to hours.

The app’s core interaction is simple: log a meal (by photo, barcode, or manual entry), then watch the glucose response develop over the following ninety minutes. The Levels app scores each meal from 0 to 100 based on three factors: peak glucose reached, time to return to baseline, and area under the curve. A score of 70 or above indicates a metabolically favorable response. Over time, you build a personal database of how your specific biology responds to specific foods and meal compositions.

The activity overlay is one of the genuinely useful features. Post-meal exercise — even a ten-minute walk — significantly flattens glucose response by increasing glucose uptake in muscle tissue. Levels makes this visible: you can observe the difference in curve shape between a meal followed immediately by sitting and the same meal followed by a short walk. For many users, this single insight — that light post-meal movement is a metabolic intervention, not just general health advice — produces lasting behavioral change that persists well beyond the subscription period.

The sleep integration connects sleep quality to fasting glucose. Poor sleep reliably elevates morning glucose for most people, reflecting the cortisol-driven glucose release that occurs with disrupted sleep architecture. Seeing this correlation represented visually, with your own data, tends to have a stronger behavioral impact than reading about it abstractly.

Full Product Breakdown

Sensors. Levels ships Abbott FreeStyle Libre 3 sensors. Application is simple: the sensor is pressed against the upper arm and automatically activates. It reads continuously for fourteen days without calibration. The sensor is water-resistant, does not require finger-prick calibration, and communicates via NFC to the iPhone app (Bluetooth on Android). The reading accuracy is clinically validated and suitable for metabolic tracking, though it measures interstitial glucose rather than blood glucose directly — readings lag blood glucose by approximately five to fifteen minutes during rapid changes.

App features. Real-time glucose graph, meal logging with photo recognition and barcode scanning, activity logging with automatic import from Apple Health and Google Fit, sleep overlay from connected wearables, monthly summary reports, pattern identification over time, and personalized insights that identify individual response patterns. The insights engine is one of the stronger features: after several weeks of data, the app surfaces observations specific to your dataset, such as identifying that your glucose response to oatmeal is consistently higher than your response to sourdough bread, or that your post-lunch crash correlates with sleep below seven hours the previous night.

Metabolic Score. A composite daily metric that reflects average glucose, time in optimal range (70-140 mg/dL), and glucose stability (standard deviation). The score provides a single number that captures the overall metabolic character of a day, useful for tracking progress over a multi-week period.

Coaching. The Pro tier includes a monthly call with a metabolic health coach. Coaching quality varies by individual coach but is generally useful for protocol design — structuring a deliberate experimental framework for the CGM period rather than logging meals randomly and hoping patterns emerge. Monthly cadence is appropriate for most users.

How It Compares

Nutrisense is the closest competitor. It uses Dexcom hardware and includes registered dietitian access as standard, which makes it a better fit for users who want structured dietary guidance alongside the data. Levels has a superior app and a more sophisticated insights engine. January AI takes an interesting approach — using CGM data to train a personalized AI model that predicts glucose response to foods you have not yet tested. For users primarily interested in prediction rather than real-time monitoring, January AI represents good value. The DIY option (purchasing CGM sensors directly through a telehealth prescriber or, in some countries, over the counter) delivers a substantial portion of the metabolic insight at significantly lower cost, but requires manual data interpretation and tracking.

The Insight That Outlasts the Subscription

Here is the aspect of CGM use that most reviews underweight: the most valuable output of a CGM period is not the real-time data. It is the behavioral modification that outlasts the sensor.

After thirty to ninety days of continuous glucose monitoring, most users have internalized their personal metabolic response patterns. They know which foods spike them and which do not. They know how meal composition affects their response — that eating protein and fiber before carbohydrates flattens their curve, or that rice paired with vegetables is metabolically neutral for them while rice eaten alone is not. They know that poor sleep elevates their morning baseline and that post-meal walking substantially reduces their peak glucose. They know which of their individually varying responses diverge most sharply from the population averages reflected in standard dietary guidance.

This knowledge does not expire when the subscription ends. The CGM created a feedback loop fast enough and specific enough to produce genuine learning. The learning then persists as behavior change that no longer requires the sensor to maintain. A three-month CGM protocol can produce a permanent personalized dietary model — one that is calibrated to your individual metabolic response rather than population averages — that continues to operate indefinitely after the sensor comes off.

This reframes the $199/month cost. If you use Levels for three months with deliberate experimental intent — testing specific foods, meal compositions, and timing strategies, using the data to identify your personal response patterns — the effective cost is $597 for a permanent, individualized metabolic baseline. That framing is more defensible than $2,388 per year for ongoing real-time monitoring most users do not require indefinitely.

Authority Verdict

Overall score: 84/100.

Recommended protocol: Two to three month initial Levels period to establish personal baselines and identify individual response patterns, with deliberate experimental intent. Then exit the subscription and apply learned protocols independently. Optional: annual 30-day metabolic audit using a direct-purchase CGM sensor to check whether patterns have shifted.

Who this is for: Founders and knowledge workers whose output is directly coupled to cognitive performance. Athletes optimizing fueling strategies for training and competition. Anyone with metabolic concerns — pre-diabetes, PCOS, metabolic syndrome — who wants individualized data rather than generic guidance. Anyone who has followed multiple dietary protocols without clear results and suspects their individual response diverges from population averages.

Who should approach differently: Anyone who cannot justify $200/month at this stage — the DIY sensor option (direct CGM purchase through a telehealth prescriber, paired with manual logging) delivers approximately 80% of the metabolic insight at roughly 20% of the cost. Users outside the US should investigate Supersapiens or local CGM options before attempting to navigate Levels’ limited international access. Anyone who is not prepared to actively log meals, review patterns, and run deliberate dietary experiments will not extract sufficient value from the platform — the sensor is not self-interpreting.

The underlying insight of Levels Health is not proprietary to the company. It is the finding from that 2015 Weizmann study, operationalized into a consumer product: your metabolic response is individual, and individualized feedback will always outperform population-average guidance. The question is whether you want to pay $199/month for the infrastructure to access that feedback, or whether you want to construct it yourself for less. Either way, the feedback loop is worth building.

Related reading: Levels Health Review: What a Continuous Glucose Monitor Reveals About Your Metabolism, Levels Health Review: The Metabolic Unhack and the Logic of Glucose-Driven Sovereignty, InsideTracker Review: The Blood Optimization Protocol for Biological Sovereignty, Zero Fasting Review: The Metabolic Dashboard for Intermittent Fasting, CGM Unlocked: How Continuous Glucose Monitoring Revolutionizes Your Nutrition.